Oncohema Key

BACKGROUND: HISTORICAL PERSPECTIVE Print Section Listen The surgical management of breast cancer has changed greatly since the late 1880s when Halsted started utilizing radical mastectomy for breast cancer treatment.1 Although…

INTRODUCTION Print Section Listen Pancreatic neuroendocrine tumors (PNETs) account for <3% of all pancreatic tumors and occur with an incidence of 1 to 2 per 100,000 people.1–3 Most are sporadic; however, they may…

OVERVIEW Print Section Listen Cystic neoplasms of the pancreas represent a diagnostic challenge for physicians. Once considered rare, over the past two decades the identification of these cysts has increased…

INTRODUCTION Print Section Listen Pancreatic ductal adenocarcinomas account for approximately 85% of all pancreatic tumors. Recently, less common epithelial tumors have been increasingly identified as a result of the frequent…

INTRODUCTION Print Section Listen Reports of the use of vascular resection at the time of pancreatectomy have circulated since Fortner attempted to popularize the techniques approximately 40 years ago. At…

BACKGROUND AND INTRODUCTION Print Section Listen Pancreatic cancer is a devastating disease that presents late and is fatal in nearly all cases. It affects about 12 per 100,000 men and…

INTRODUCTION Print Section Listen Pancreatic neuroendocrine tumors (PNETs) are thought to arise from mature endocrine cells in the pancreas and/or pleuripotent stem cells that have the capacity to differentiate into…

INTRODUCTION Print Section Listen Cancer staging systems have been designed to provide both physicians and patients with a metric for assessing the extent of disease and prognosis. Staging systems provide…

INTRODUCTION Print Section Listen Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer-related deaths in the United States and the eighth worldwide. Despite advances in medical therapy, survival…